McKesson has reported full-year revenues of $264bn, an increase of 11% from the prior year. The US pharmaceutical giant said that its transformation to a diversified healthcare services company is working, primarily driven by growth in the US.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.